Showing results (331-340 of 439) with videos related to

Sort By:
Pageof 44
European Heart Journal|June 29, 2021
Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trialCarolyn S P Lam, João Pedro Ferreira, Egon Pfarr, et al.
American Heart Journal|April 24, 2023
Fatal, ischemic and bleeding risk of patients meeting the selection criteria of the TWILIGHT trial: Insights from a large PCI registryAlessandro Spirito, Won-Joon Koh, Samantha Sartori, et al.
Circulation. Cardiovascular Quality and Outcomes|January 5, 2019
Tailoring Antiplatelet Therapy Intensity to Ischemic and Bleeding RiskUsman Baber, Daniel E Leisman, David J Cohen, et al.
Journal of the American Heart Association|December 24, 2022
Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic CauseMuhammad Shahzeb Khan, Javed Butler, Stefan D Anker, et al.
Clinical Cardiology|November 13, 2019
Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registryStuart J Pocock, David Brieger, John Gregson, et al.
European Heart Journal|July 5, 2019
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trialsPaul Guedeney, Gennaro Giustino, Sabato Sorrentino, et al.
Diabetes Research and Clinical Practice|March 25, 2019
Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER studyMarilia B Gomes, Wolfgang Rathmann, Bernard Charbonnel, et al.
Journal of Cardiology|December 3, 2021
Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: Insights from the TIGRIS registryJuan J Russo, Andrew T Yan, Stuart J Pocock, et al.
European Heart Journal|January 18, 2021
Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trialMilton Packer, Stefan D Anker, Javed Butler, et al.
European Journal of Heart Failure|July 14, 2025
Coordinated expression of BMP10/ALK1/endoglin-proteins that drive embryonic cardiac and vascular morphogenesis-in patients with heart failure: The EMPEROR ProgramMilton Packer, Javed Butler, João Pedro Ferreira, et al.
Pageof 44